Cancer: The Evolutionary Legacy by Greaves, Mel

Cancer: The Evolutionary Legacy

byGreaves, Mel

Paperback | October 15, 2001

not yet rated|write a review

Pricing and Purchase Info

$129.50 online 
$259.00 list price
Earn 648 plum® points

Out of stock online

Not available in stores


In this lucid and entertaining book, Mel Greaves argues that evolutionary biology offers a new perspective that can help us unravel the riddle of cancer. Why, for example, have women always had such a raw deal in the cancer stakes? And why are some cancers, such as prostate cancer, increasingin incidence? Greaves argues that Darwinian selection millions of years ago has endowed our genes and cells with inherently cancerous credentials, and this is exacerbated by our rapid social evolution and exotic behavioural traits that outpace genetic adaptation. The book is full of novel insights, the latestscientific discoveries, and wonderful historical anecdotes. It provides a unique portrait of cancer, past, present, and future.

About The Author

Mel Greaves is at Institute for Cancer Research, London.
Frontiers in Cancer Research: Evolutionary Foundations, Revolutionary Directions
Frontiers in Cancer Research: Evolutionary Foundations, Revolutionary Directions

by Mel Greaves


Available for download

Not available in stores

Krebs - der blinde Passagier der Evolution
Krebs - der blinde Passagier der Evolution

by Mel F. Greaves


In stock online

Not available in stores

Details & Specs

Title:Cancer: The Evolutionary LegacyFormat:PaperbackDimensions:288 pages, 9.21 × 6.14 × 0.63 inPublished:October 15, 2001Publisher:Oxford University PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0192628348

ISBN - 13:9780192628343

Look for similar items by category:

Customer Reviews of Cancer: The Evolutionary Legacy


Extra Content

Table of Contents

PrefacePART I: CANCER - ANCIENT LEGACIES AND MODERN MYTHS1. Perplexed? You should be2. The King of Naples and other silent witnesses3. Questions and answersPART II: EVOLVING CANCER4. Clones, clones, clones5. The way we are: risk and restraints6. How cancer cells play the winning game7. Green-eyed mutations?8. Blind chance - and ultimate extinction?PART III: PARADOXES OF PROGRESS: INDECENT EXPOSURES9. Is cancer an evolutionary inevitability?10. And then you set fire to it?11. Women's troubles12. Men's troubles13. Cancer a deux14. Other ways of getting bugged15. Travelling light16. Dying for a living17. Collateral damage18. Finale: compounding risk with bad luckPART IV: FINESSING THE CLONE19. Treatment: the blind marksman20. Epilogue: cancer in the 21st centuryIndex